Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Analytics

Trial Phases

No phase data

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
Interstitial Lung DiseasesSystemic Sclerosis
Principalinvestigator

Research Network

Collaboration Network

8 collaborators·8 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Royal Free Hospital, University College London London

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Paul Szabolcs, MD

University of Pittsburgh

Moderately Similar
6 trials

Shared therapeutic areas:

Lung Diseases, InterstitialScleroderma, Systemic
Similarity Score30%

Gabriela Riemekasten, Prof.

Charité Universitätsmedizin Berlin, Charité Centrum 12 für Innere Medizin und Dermatologie, Medizinische Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie

Related
1 trials

Shared therapeutic areas:

Lung Diseases, InterstitialScleroderma, Systemic

Worked with same sponsors:

Charite University, Berlin, GermanyEuropean Union+11 more
Collaborated on 1 trial
Similarity Score24%

Ulf Müller-Ladner, Prof.

Justus-Liebig-University Gießen, Kerckhoff Clinic, Departement of Rheumatology and Clinical Immunology

Related
5 trials

Shared therapeutic areas:

Scleroderma, SystemicLung Diseases, Interstitial

Worked with same sponsors:

Charite University, Berlin, GermanyEuropean Union+11 more
Collaborated on 1 trial
Similarity Score24%

Konrad E Bloch, MD

University Hospital, Zürich

Related
19 trials

Shared therapeutic areas:

Lung Diseases, Interstitial

Worked with same sponsors:

University of Zurich
Similarity Score15%

loic MONDOLONI

Assistance Publique Hopitaux De Marseille

Related
28 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score15%

Silvia Ulrich, Prof. Dr.

University Hospital Zurich, Department of Pulmonology

Related
8 trials

Shared therapeutic areas:

Lung Diseases, Interstitial

Worked with same sponsors:

University of Zurich
Similarity Score15%

Deran Oskay, Prof

Gazi University

Related
6 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score15%

Mohamed AbdElmoniem

Lecturer of chest medicine faculty of medicine Mansoura university

Related
13 trials

Shared therapeutic areas:

Lung Diseases, Interstitial
Similarity Score15%

Zeynep Betül ÖZCAN, M. Sc.

Saglik Bilimleri Universitesi

Related
3 trials

Shared therapeutic areas:

Lung Diseases, Interstitial
Similarity Score15%

Chadwick Prodromos, MD

The Foundation for Orthopaedics and Regenerative Medicine

Related
20 trials

Shared therapeutic areas:

Scleroderma, Systemic
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01858259PrincipalInvestigator

Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis

Interstitial Lung DiseasesSystemic Sclerosis
Unknown

All 1 trials loaded